Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG
ACS Infectious Diseases · 2023
DOI: 10.1021/acsinfecdis.2c00570 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2023. Verfasst von Li-Rong Mao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Anhui University of Science and Technology, Huainan 232001, China. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Mycobacterium bovis, Tuberculosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Scientific Research Foundation of Education Department of Anhui Province of China, Graduate Student Innovation Fund, University Natural Science Research Project of Anhui Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Medicine, Anhui University of Science and Technology, Huainan 232001, China.
- Department of Pathogen Biology, School of Medicine, Anhui University of Science and Technology, Huainan 232001, China.
- Department of Cosmetology, School of Medicine, Huainan Union University, Huainan 232038, China.
- Department of Clinical Laboratory, Huainan Chaoyang Hospital, Huainan 232007, China.
- Department of Clinical Laboratory, Affiliated Cancer Hospital, Anhui University of Science and Technology, Huainan 232035, China.
- Department of Clinical Laboratory, Anhui Zhongke Gengjiu Hospital, Hefei 230000, China.
ORCID-Profile: Li-Rong Mao, Li-Fa Xu
Förderung
- Scientific Research Foundation of Education Department of Anhui Province of China
- Graduate Student Innovation Fund
- University Natural Science Research Project of Anhui Province
Zitieren
APA
Mao, L. R., Du, J. P., Wang, X. C., Xu, L. F., Zhang, Y. P., Sun, Q. S., Shi, Z. L., Xing, Y. R., Su, Y. X., Wang, S. J., Wang, J., Ma, J. L., & Zhang, J. Y. (2023). Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.2c00570
Vancouver
Mao LR, Du JP, Wang XC, Xu LF, Zhang YP, Sun QS, et al. Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG. ACS Infectious Diseases. 2023. doi:10.1021/acsinfecdis.2c00570
BibTeX
@article{Mao2023,
author = {Mao, Li-Rong and Du, Jian-Peng and Wang, Xiao-Chun and Xu, Li-Fa and Zhang, Yan-Peng and Sun, Qi-Shan and Shi, Zi-Lun and Xing, Ying-Ru and Su, Yi-Xin and Wang, Sheng-Jian and Wang, Jian and Ma, Ji-Lei and Zhang, Jing-Yan},
title = {Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG},
journal = {ACS Infectious Diseases},
year = {2023},
doi = {10.1021/acsinfecdis.2c00570}
}
EUVIMED